My Focus and Background

I am interested in using cancer genomics combined with phenotypic screening to identify and validate novel oncology drug targets.

Following my postdoc at Onyx pharmaceuticals, I moved to UCSF to start a lab working on signaling pathways deregulated in cancer. I then joined Genentech to apply some of these findings more translationally, as well as pursuing target identification, through cancer genomics and analysis of epigenetic alterations.